Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?

Endocrine
Klaire ExarchouChristos Toumpanakis

Abstract

Type III gastric neuroendocrine neoplasms (g-NENs) have historically been regarded as aggressive tumours, hence current guidelines advocate radical surgery with lymph node dissection. Data on the roles of endoscopic or less extensive surgical resections are more limited. The aim of our study is to evaluate the clinicopathological features and long-term outcomes of patients undergoing endoscopic or limited surgical resection for localised grade 1 or 2 type III g-NENs when compared to radical surgery. Retrospective analysis of all patients diagnosed with a localised grade 1 or 2 type III g-NENs across six tertiary NEN centers between 2006 and 2019. Forty-five patients were diagnosed with a potentially resectable grade 1 or 2 type III g-NEN of whom 36 underwent either endoscopic or surgical resection. No statistically significant differences were found between the three resection groups in terms of patient age, tumour location, grade or size. Only tumour size was found to be significantly associated with poor clinical outcome (p = 0.012) and ROC curve analysis identified tumour size >10 mm as a negative predictor (AUC:0.8030, p = 0.0021). Tumours >10 mm were also more likely to be associated with lymph node metastases on imaging a...Continue Reading

References

Mar 3, 2004·Journal of Surgical Oncology·Woo Jin HyungSung Hoon Noh
Oct 25, 2006·Alimentary Pharmacology & Therapeutics·M D Burkitt, D M Pritchard
Mar 6, 2007·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Takuji Gotoda
Jul 8, 2008·Endocrine-related Cancer·Ulrich-Frank PapeBertram Wiedenmann
Jul 29, 2010·Pancreas·Matthew H KulkeUNKNOWN North American Neuroendocrine Tumor Society (NANETS)
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco PanzutoMassimo Falconi
Dec 30, 2011·Neuroendocrinology·Francesco PanzutoMassimo Falconi
Jan 21, 2012·Neuroendocrinology·Gianfranco Delle FaveUNKNOWN Barcelona Consensus Conference participants
Nov 22, 2012·Gut and Liver·Michelle Kang Kim
Jun 5, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Fabia AttiliAlberto Larghi
Jun 27, 2013·World Journal of Gastroenterology : WJG·Srinivas R PuliDavid Forcione
Jan 1, 2014·World Journal of Gastroenterology : WJG·Yong Hwan KwonJeong Seop Moon
Mar 19, 2014·Alimentary Pharmacology & Therapeutics·R BasuroyJ K Ramage
Jan 6, 2016·Neuroendocrinology·U-F PapeUNKNOWN Vienna Consensus Conference participants
Jan 6, 2016·Neuroendocrinology·J K RamageUNKNOWN Vienna Consensus Conference participants
Jan 20, 2016·Neuroendocrinology·G Delle FaveUNKNOWN Vienna Consensus Conference participants
Oct 22, 2016·Journal of Surgical Oncology·Lauren M PostlewaitShishir K Maithel
Nov 6, 2017·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Alessandra ZilliSara Massironi
Jun 13, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Manisha H ShahGriselda Zuccarino-Catania
Jun 13, 2018·The British Journal of Surgery·B-H MinJ J Kim
Aug 23, 2019·Histopathology·Iris D NagtegaalUNKNOWN WHO Classification of Tumours Editorial Board
May 12, 2020·Alimentary Pharmacology & Therapeutics·Klaire ExarchouDavid Mark Pritchard
Jun 25, 2020·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Toshiaki HirasawaTakeshi Sano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.